Reviva Pharmaceuticals Holdings annual return on equity
2020
2021
2022
2023
2024
2025
Reviva Pharmaceuticals Holdings Return on Equity (ROE) Growth & History (RVPH)
Reviva Pharmaceuticals Holdings's return on equity was −419.97% for fiscal 2025.
View full Reviva Pharmaceuticals Holdings company overviewReviva Pharmaceuticals Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −419.97% | +496.20 pp |
| 2024 | 2024-12-31 | −916.17% | −359.79 pp |
| 2023 | 2023-12-31 | −556.38% | −403.95 pp |
| 2022 | 2022-12-31 | −152.43% | −102.53 pp |
| 2021 · Dec 31 | 2021-12-31 | −49.91% | +22.40 pp |
| 2020 · Dec 31 | 2020-12-31 | −72.30% | — |
Reviva Pharmaceuticals Holdings quarterly return on equity
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q1.24
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.00% | — |
| Q1 2026 | 2026-03-31 | −24.50% | — |
| Q4 2025 | 2025-12-31 | −51.04% | — |
| Q3 2025 | 2025-09-30 | −196.10% | — |
| Q1 2024 | 2024-03-31 | −339.99% | −203.06 pp |
| Q1 2023 | 2023-03-31 | −136.93% | −107.49 pp |
| Q4 2022 | 2022-12-31 | −70.29% | −58.20 pp |
| Q3 2022 | 2022-09-30 | −29.93% | −23.11 pp |
| Q2 2022 | 2022-06-30 | −28.54% | −20.30 pp |
| Q1 2022 | 2022-03-31 | −29.43% | −10.41 pp |
| Q4 2021 | 2021-12-31 | −12.09% | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −6.82% | — |
| Q2 2021 · Jun 30 | 2021-06-30 | −8.24% | — |
| Q1 2021 · Mar 31 | 2021-03-31 | −19.02% | — |
| Q3 2021 · Nov 30 | 2020-11-30 | −6.96% | −9.70 pp |
| Q2 2021 · Aug 31 | 2020-08-31 | −10.32% | −15.81 pp |
| Q1 2021 · May 31 | 2020-05-31 | −3.12% | −9.88 pp |
| Q3 2020 | 2019-11-30 | 2.74% | −2.53 pp |
| Q2 2020 | 2019-08-31 | 5.49% | — |
| Q1 2020 · May 31 | 2019-05-31 | 6.77% | — |
| Q4 2019 | 2019-02-28 | 6.13% | — |
| Q3 2019 | 2018-11-30 | 5.26% | — |
Reviva Pharmaceuticals Holdings return on equity trends
Over the last five fiscal years, Reviva Pharmaceuticals Holdings's return on equity decreased from −72.30% to −419.97%, a change of −347.67 percentage points. The latest reported quarter, Q2 2026, shows −15.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Reviva Pharmaceuticals Holdings source filings ↗